ArticleGastroenterology report2026
Endoscopic ultrasound versus direct transjugular portal pressure gradient in patients receiving TIPS: influence of portal vein thrombosis.
Article in Gastroenterology report, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Endoscopic ultrasound (EUS) has emerged as a valuable tool for assessing portal hypertension (PH). Our study aimed to compare endoscopic ultrasound-guided portal pressure gradient (EUS-PPG) with directly measured transjugular PPG (T-PPG) and hepatic venous pressure gradient (HVPG) during transjugular intrahepatic portosystemic shunt (TIPS). Methods: Consecutive patients scheduled for elective TIPS between March 2023 and December 2024 were included. EUS was performed using a 22-gauge FNA needle attached to an invasive pressure monitoring module. TIPS placement and HVPG were performed according to the standard methods. Results: Twenty-four patients who underwent elective TIPS for PH-related complications were enrolled (mean age 56.4 ± 8.8 years, model of end-stage liver disease [MELD] 15.0 ± 5.5). The technical success rates for EUS-PPG and HVPG were 92.3% and 100%, respectively. There was a strong correlation between EUS-PPG and T-PPG ( Conclusion: EUS-PPG demonstrates strong reliability when compared to direct PPG measurements obtained during TIPS insertion. Using a 22-gauge needle, EUS-PPG proved to be accurate and safe for assessing PH. The presence of PVT may be a cofounder of discrepancy between the direct methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.